Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient
Publication status
publishedExternal links
Journal / series
Journal of Cancer Research and Clinical OncologyVolume
Pages / Article No.
Publisher
SpringerSubject
Prostate cancer; Prostatic hyperplasia; ED-B fibronectin; Vascular targeting; Pharmacodelivery; 131I-L19SIP dosimetryOrganisational unit
03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
More
Show all metadata
ETH Bibliography
yes
Altmetrics